Trial intelligence / Profile preview

Anti-inflammatory Effect of Ketamine in Cardiac Surgery

NCT07536633Phase 4Completed

Sponsor
Konya City Hospital
Start
Oct 2022
Primary completion
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ketamine in Systemic Inflammatory Response Syndrome (SIRS), sponsored by Konya City Hospital. Started Oct 2022; status: completed.

02

Drugs

ketamine
03

Conditions

Systemic Inflammatory Response Syndrome (SIRS)

Beyond the preview

Go deeper on NCT07536633.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07536633.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call